Anzeige
❌
Mehr »
Sonntag, 22.11.2026 - Börsentäglich über 12.000 News
Zufall oder Strategie? Copper One zündet die nächste Stufe seiner Kupfer-Offensive!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
SaThe Oral GLP-1 Tracker: Foundayo holds steady as Wegovy pill takes a 5% dip
FrMapping psychedelics' commercial summit
FrMerck scores US, German wins over Halozyme in Keytruda Qlex patent fight
FrFDA sets up new safety council to keep tabs on approved vaccines, cell and gene therapies
FrAnother 215 layoffs linked to Novo's New Jersey HQ
FrFierce Pharma Asia-Ivonescimab's FDA snub; Pfizer's in vivo CAR-T deal; China fires scientists in fatal gene trial
FrSanofi gets Genzyme asset across FDA finish line with key nod in Gaucher type 3
DoFacing down Dupixent cliff, Sanofi mulls buyout of Insmed and its blockbuster-to-be Brinsupri: Bloomberg
DoBiogen unblurs life with Friedreich ataxia in patient-centered Skyclarys campaign
DoRegeneron breaks into neurology with FDA nod in crowded myasthenia gravis
DoArcera strikes $1B+ pact to license Innogen's approved GLP-1 outside China
DoNovartis CEO, staring down $16.7B post-2030 patent cliff, challenges Wall Street consensus
DoJ&J draws FDA rebuke for misstating Inlexzo's bladder-sparing benefits
DoCDMO Lotte inks commercial production deal as work on South Korean plant wraps
DoThe GLP-1 Paradox: Strong Clinical Evidence, Weak Persistence Rates
MiBMS' ph. 3 Alzheimer's psychosis teaser builds confidence in Cobenfy expansion plan
MiAI's Real Prize: Building Tomorrow's CI Capability
MiBeren clinches long-awaited FDA nod for cyclodextrin drug in Niemann-Pick disease
MiFDA moves to yank Salerno's liquid cholesterol drug approval on missing reports
MiNovo expands DTC program Novocare to support Wegovy users through holistic health journey
MiHeidi Overton's FDA nomination pulled by White House: reports
DiFDA's complete response letter for Summit's ivonescimab cites China-heavy data beyond survival miss
DiGSK scores FDA approval for Nelkarmi, its 2nd lung cancer drug from Nuvalent deal
DiCosentyx bags FDA nod for 11th indication as Novartis looks to buffer 2029 patent cliff
DiViatris takes the wheel as Cadillac F1 team's new global pharma partner